Cite
Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: a consensus statement.
MLA
Chaddha, Udit, et al. “Use of Fibrinolytics and Deoxyribonuclease in Adult Patients with Pleural Empyema: A Consensus Statement.” The Lancet. Respiratory Medicine, vol. 9, no. 9, Sept. 2021, pp. 1050–64. EBSCOhost, https://doi.org/10.1016/S2213-2600(20)30533-6.
APA
Chaddha, U., Agrawal, A., Feller-Kopman, D., Kaul, V., Shojaee, S., Maldonado, F., Ferguson, M. K., Blyth, K. G., Grosu, H. B., Corcoran, J. P., Sachdeva, A., West, A., Bedawi, E. O., Majid, A., Mehta, R. M., Folch, E., Liberman, M., Wahidi, M. M., Gangadharan, S. P., … Rahman, N. M. (2021). Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: a consensus statement. The Lancet. Respiratory Medicine, 9(9), 1050–1064. https://doi.org/10.1016/S2213-2600(20)30533-6
Chicago
Chaddha, Udit, Abhinav Agrawal, David Feller-Kopman, Viren Kaul, Samira Shojaee, Fabien Maldonado, Mark K Ferguson, et al. 2021. “Use of Fibrinolytics and Deoxyribonuclease in Adult Patients with Pleural Empyema: A Consensus Statement.” The Lancet. Respiratory Medicine 9 (9): 1050–64. doi:10.1016/S2213-2600(20)30533-6.